Department of Neurosurgery, Penn State Health, Hershey, Pennsylvania, USA.
Department of Neurosurgery, Penn State Health, Hershey, Pennsylvania, USA.
World Neurosurg. 2021 Jul;151:218-224.e2. doi: 10.1016/j.wneu.2021.04.083. Epub 2021 Apr 30.
Frequency of clinical seizures may be as high as 16% in patients with spontaneous intracerebral hemorrhage (ICH). Current guidelines recommend against antiepileptic drug (AED) prophylaxis, but this recommendation is based on older trials, and the effect of newer AEDs is uncertain. The aim of this review was to study effects of AEDs on seizure occurrence and outcome in patients with spontaneous ICH.
We searched key databases using combinations of the following terms: "levetiracetam," "prophylaxis," "ICH," "intracerebral hemorrhage," "intraparenchymal hemorrhage." Selected studies were reviewed for level of evidence and overall quality of data using Grading of Recommendations, Assessment, Development and Evaluations criteria. A meta-analysis was performed to evaluate seizure prevention, functional outcome, and mortality in patients with seizure prophylaxis compared with no prophylaxis following spontaneous ICH.
Seven articles met inclusion criteria and were graded level III studies. Administration of AEDs was not associated with reduced seizure risk (odds ratio 1.14, 95% confidence interval 0.47-2.77, P = 0.77). There was an association between AED prophylaxis and poor functional outcome (odds ratio 1.65, 95% confidence interval 1.17-2.31, P = 0.004) but not mortality (odds ratio 1.04, 95% confidence interval 0.62-1.72, P = 0.89). The overall quality of evidence using Grading of Recommendations, Assessment, Development and Evaluations criteria was low.
This systematic review and meta-analysis including recent studies focusing on newer AEDs supports the 2015 guidelines regarding AED use in spontaneous ICH. There are some important caveats, including a possible confounding association between AED use and higher ICH score and the overall poor quality of the available data. A randomized clinical trial may be helpful.
自发性脑出血(ICH)患者的临床发作频率可能高达 16%。目前的指南反对使用抗癫痫药物(AED)进行预防,但这一建议是基于早期试验的,而新型 AED 的效果尚不确定。本综述的目的是研究 AED 对自发性 ICH 患者癫痫发作的发生和结局的影响。
我们使用以下术语的组合在主要数据库中进行搜索:“左乙拉西坦”、“预防”、“ICH”、“脑出血”、“脑实质出血”。使用推荐评估、制定与评价(Grading of Recommendations, Assessment, Development and Evaluations)标准对选定的研究进行评估,以确定其证据水平和数据整体质量。对预防性使用 AED 与未预防性使用 AED 相比自发性 ICH 后预防癫痫发作、功能结局和死亡率的研究进行了荟萃分析。
有 7 篇文章符合纳入标准,被评为 III 级研究。使用 AED 并不能降低癫痫发作的风险(比值比 1.14,95%置信区间 0.47-2.77,P=0.77)。AED 预防与不良功能结局之间存在关联(比值比 1.65,95%置信区间 1.17-2.31,P=0.004),但与死亡率无关(比值比 1.04,95%置信区间 0.62-1.72,P=0.89)。使用 Grading of Recommendations, Assessment, Development and Evaluations 标准评估的证据整体质量较低。
包括最近关注新型 AED 的研究在内的这项系统综述和荟萃分析支持 2015 年自发性 ICH 中使用 AED 的指南。但有一些重要的注意事项,包括 AED 使用与较高的 ICH 评分之间可能存在混淆关联,以及现有数据的整体质量较差。一项随机临床试验可能会有所帮助。